American may receive the Pfizer/BioNTech vaccine on Monday, says US HHS Azar
|US Health Secretary Alex Azar has said that Americans might begin receiving the Pfizer/BioNTech COVID-19 vaccine on Monday.
The US Food and Drugs Administration has accelerated work toward finalizing the approval of the vaccine after an advisory panel voted 17 to 4 in favor of granting emergency use. President Donald Trump has urged authorities to move forward with greenlighting the jabs.
The pharmaceutical companies showed a 95% efficacy rate in defending against coronavirus in its Phase 3 test, without showing any severe adverse side effects.
Moderna's incolucaiton also successfully completed its Phase 3 trial and uses the same mRNA technology like Pfizer. The FDA is set to discuss its application on Thursday, December 17.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.